Subject
General Biochemistry, Genetics and Molecular Biology
Reference89 articles.
1. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012
2. Safety and antitumor activity of anti-PD-1 antibody, Nivolumab, in patients with platinum-resistant ovarian cancer;Hamanishi;J. Clin. Oncol.,2015
3. Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: a phase Ib, open-label expansion trial;Disis;J. Clin. Oncol.,2015
4. Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: interim results from a phase Ib study;Varga;J. Clin. Oncol.,2015
5. Integrated genomic analyses of ovarian carcinoma;Berchuck;Nature,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献